PHS

Pharsight

Stock
Stock
ISIN: US71721Q2003
Ticker: PHST
US71721Q2003
PHST

Price

Price

CHART BY

Frequently asked questions

What is the Earnings Per Share (EPS) for Pharsight?

Pharsight's Earnings Per Share (EPS) over the trailing twelve months (TTM) is 0.16. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Pharsight's stock?

Currently, 1 analysts cover Pharsight's stock, with a consensus target price of $10.00. Analyst ratings provide insights into the stock's expected performance.

What is Pharsight's revenue over the trailing twelve months?

Over the trailing twelve months, Pharsight reported a revenue of $28.84M.

What is the EBITDA for Pharsight?

Pharsight's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $2.22M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Pharsight?

Pharsight has a free cash flow of $3.68M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Pharsight have, and what sector and industry does it belong to?

Pharsight employs approximately 113 people. It operates in the Information Technology sector, specifically within the Packaged Software industry.

Financials

EPS (TTM) 
0.16
Revenue (TTM) 
$28.84M
EBITDA (TTM) 
$2.22M
Free Cashflow (TTM) 
$3.68M

Analyst Ratings

The price target is $10.00 and the stock is covered by 1 analysts.

Buy

0

Hold

0

Sell

1

Information

Pharsight's products and services help drugmakers build and shape their pipelines and decrease time and money spent on development. Using computer simulation, statistics, and data analysis along with pharmacology, disease and drug modeling, genetics, and databases of biologic information, Pharsight helps clients determine drug-development targets.

Employees
113
Industries
Packaged Software
Sector
Information Technology

Identifier

ISIN
US71721Q2003
Primary Ticker
PHST

Knockouts

Join the conversation